An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level

PLINK: a tool set for whole-genome association and population-based linkage analyses.

Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089

An integrated encyclopedia of DNA elements in the human genome

The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072

Systematic Localization of Common Disease-Associated Variation in Regulatory DNA

Maurano, M. T., Humbert, R., Rynes, E., Thurman, R. E., Haugen, E., Wang, H., Reynolds, A. P., Sandstrom, R., Qu, H., Brody, J., et al. (2012) · Science · doi:10.1126/science.1222794 · Cited by 3,716

Mapping and analysis of chromatin state dynamics in nine human cell types

Ernst, J., Kheradpour, P., Mikkelsen, T. S., Shoresh, N., Ward, L. D., Epstein, C. B., Zhang, X., Wang, L., Issner, R., Coyne, M., et al. (2011) · Nature · doi:10.1038/nature09906 · Cited by 2,898

The accessible chromatin landscape of the human genome

Thurman, R. E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M. T., Haugen, E., Sheffield, N. C., Stergachis, A. B., Wang, H., Vernot, B., et al. (2012) · Nature · doi:10.1038/nature11232 · Cited by 2,679

Rare-Variant Association Testing for Sequencing Data with the Sequence Kernel Association Test

Wu, M. C., Lee, S., Cai, T., Li, Y., Boehnke, M., & Lin, X. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.05.029 · Cited by 2,373

Genome editing with engineered zinc finger nucleases

Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285

A TALE nuclease architecture for efficient genome editing

Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098

Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting

Čermák, T., Doyle, E., Christian, M. L., Wang, L., Zhang, Y., Schmidt, C. L., Baller, J. A., Somia, N. V., Bogdanove, A. J., & Voytas, D. F. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr218 · Cited by 2,034

TALENs: A widely applicable technology for targeted genome editing

Joung, J. K., & Sander, J. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3486 · Cited by 1,650

A CRISPR focus on attitudes and beliefs toward somatic genome editing from stakeholders within the sickle cell disease community

Persaud, A., Desine, S., Blizinsky, K. D., & Bonham, V. L. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0409-6 · Cited by 46

Applications of CRISPR-Cas9 for advancing precision medicine in oncology: from target discovery to disease modeling

Ravichandran, M., & Maddalo, D. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1273994 · Cited by 47

Genetic Variation and Sickle Cell Disease Severity

Kirkham, J. K., Estepp, J. H., Weiss, M. J., & Rashkin, S. R. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.37484 · Cited by 48

Switching from fetal to adult hemoglobin

Wang, X., & Thein, S. L. (2018) · Nature Genetics · doi:10.1038/s41588-018-0094-z · Cited by 48

Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene

Lalonde, S., Codina-Fauteux, V.-A., de Bellefon, S. M., Leblanc, F., Beaudoin, M., Simon, M.-M., Dali, R., Kwan, T., Lo, K. S., Pastinen, T., et al. (2019) · Genome biology · doi:10.1186/s13059-019-1749-5 · Cited by 44

Regulating the Regulators: The Role of Histone Deacetylase 1 (HDAC1) in Erythropoiesis

Kim, M. Y., Yan, B., Huang, S., & Qiu, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228460 · Cited by 47

Decoding the role of regulatory element polymorphisms in complex disease

Vockley, C. M., Barrera, A., & Reddy, T. E. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.10.007 · Cited by 43

Concise Review: Epigenetic Regulation of Hematopoiesis: Biological Insights and Therapeutic Applications

Antoniani, C., Romano, O., & Miccio, A. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0192 · Cited by 50

Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease

Gupta, A. O., Sharma, A., Frangoul, H., Kanter, J., Mapara, M. Y., Dalal, J. D., Alavi, A., Jaroscak, J., Ayala, E., DiPersio, J. F., et al. (2026) · New England Journal of Medicine · doi:10.1056/nejmoa2504835 · Cited by 45

Approaches for establishing the function of regulatory genetic variants involved in disease

Knight, J. C. (2014) · Genome Medicine · doi:10.1186/s13073-014-0092-4 · Cited by 45

Dual function NFI factors control fetal hemoglobin silencing in adult erythroid cells

Qin, K., Huang, P., Feng, R., Keller, C. A., Peslak, S. A., Khandros, E., Saari, M. S., Lan, X., Mayuranathan, T., Doerfler, P. A., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01076-1 · Cited by 43

BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia

Sebastiani, P., Farrell, J. J., Alsultan, A., Wang, S., Edward, H. L., Shappell, H., Bae, H., Milton, J. N., Baldwin, C. T., Al-Rubaish, A. M., et al. (2015) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2015.01.001 · Cited by 41

Recent trends for novel options in experimental biological therapy of β-thalassemia

Finotti, A., & Gambari, R. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.927434 · Cited by 40

Single-cell analysis of bone marrow–derived CD34+ cells from children with sickle cell disease and thalassemia

Peng, H., Roy, N. B. A., de la Fuente, J., Wang, G., Thongjuea, S., Clark, K., Roy, A., Psaila, B., Ashley, N., Harrington, Y., et al. (2019) · Blood · doi:10.1182/blood.2019002301 · Cited by 39

Understanding heterogeneity of fetal hemoglobin induction through comparative analysis of F and A-erythroblasts

Khandros, E., Huang, P., Peslak, S. A., Sharma, M., Abdulmalik, O., Giardine, B. M., Zhang, Z., Keller, C. A., Hardison, R. C., & Blobel, G. A. (2020) · Blood · doi:10.1182/blood.2020005058 · Cited by 40

Genetics and Genomics of Coronary Artery Disease

Pjanic, M., Miller, C. L., Wirka, R. C., Kim, J. B., DiRenzo, D. M., & Quertermous, T. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0777-y · Cited by 40

Autologous gene therapy for hemoglobinopathies: From bench to patient’s bedside

Locatelli, F., Cavazzana, M., Frangoul, H., de la Fuente, J., Algeri, M., & Meisel, R. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.03.005 · Cited by 43

Beyond transfusion therapy: new therapies in thalassemia including drugs, alternate donor transplant, and gene therapy

Porter, J. B. (2018) · Hematology · doi:10.1182/asheducation-2018.1.361 · Cited by 40

14q32 and let-7 microRNAs regulate transcriptional networks in fetal and adult human erythroblasts

Lessard, S., Beaudoin, M., Orkin, S. H., Bauer, D. E., & Lettre, G. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy051 · Cited by 38

ATF4 Regulates MYB to Increase γ-Globin in Response to Loss of β-Globin

Boontanrart, M. Y., Schröder, M., Stehli, G., Banović, M., Wyman, S. K., Lew, R. J., Bordi, M., Gowen, B. G., DeWitt, M. A., & Corn, J. E. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107993 · Cited by 41

Hematopoietic Stem Cell-Targeted Gene-Addition and Gene-Editing Strategies for β-hemoglobinopathies

Drysdale, C. M., Nassehi, T., Gamer, J., Yapundich, M., Tisdale, J. F., & Uchida, N. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.01.001 · Cited by 39

Pharmacological and molecular approaches for the treatment of β‐hemoglobin disorders

Lohani, N., Bhargava, N., Munshi, A., & Ramalingam, S. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26292 · Cited by 38

CRISPR-Cas Technology as a Revolutionary Genome Editing tool: Mechanisms and Biomedical Applications

Ebrahimi, S., Khosravi, M. A., Raz, A., Karimipoor, M., & Parvizi, P. (2023) · ̒Ulūm va funūn-i bastah/bandī · doi:10.61186/ibj.27.5.219 · Cited by 40

Genetic therapies for sickle cell disease

Esrick, E. B., & Bauer, D. E. (2018) · Seminars in Hematology · doi:10.1053/j.seminhematol.2018.04.014 · Cited by 39

POGZ Is Required for Silencing Mouse Embryonic β-like Hemoglobin and Human Fetal Hemoglobin Expression

Gudmundsdottir, B., Gudmundsson, K. O., Klarmann, K. D., Singh, S. K., Sun, L., Singh, S., Du, Y., Coppola, V., Stockwin, L. H., Nguyen, N., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.043 · Cited by 37

Gene therapies for transfusion dependent β‐thalassemia: Current status and critical criteria for success

Soni, S. (2020) · American Journal of Hematology · doi:10.1002/ajh.25909 · Cited by 37

Gene Therapy of the Hemoglobinopathies

Kunz, J. B., & Kulozik, A. E. (2020) · HemaSphere · doi:10.1097/hs9.0000000000000479 · Cited by 40

Non-Transfusion-Dependent Thalassemia: A Panoramic Review

Shash, H. A. (2022) · Medicina · doi:10.3390/medicina58101496 · Cited by 37

Impact of Genetic Variation on CRISPR-Cas Targeting

Canver, M. C., Joung, J. K., & Pinello, L. (2018) · The CRISPR Journal · doi:10.1089/crispr.2017.0016 · Cited by 36

Sasquatch: predicting the impact of regulatory SNPs on transcription factor binding from cell- and tissue-specific DNase footprints

Schwessinger, R., Suciu, M. C., McGowan, S. J., Telenius, J., Taylor, S., Higgs, D. R., & Hughes, J. R. (2017) · Genome Research · doi:10.1101/gr.220202.117 · Cited by 35

Noncoding variants alter GATA2 expression in rhombomere 4 motor neurons and cause dominant hereditary congenital facial paresis

Tenney, A. P., Gioia, S. A. D., Webb, B. D., Chan, W. M., de Boer, E., Garnai, S. J., Barry, B. J., Ray, T., Kosicki, M., Robson, C. D., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01424-9 · Cited by 31

Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells

Zeng, J., Nguyen, M. A., Liu, P., da Silva, L. F., Levesque, S., Lin, L. Y., Justus, D. G., Petri, K., Clement, K., Porter, S. N., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.11.001 · Cited by 36

Gene therapy and gene editing strategies for hemoglobinopathies

Lidonnici, M. R., & Ferrari, G. (2018) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.12.001 · Cited by 34

NBEAL1 controls SREBP2 processing and cholesterol metabolism and is a susceptibility locus for coronary artery disease

Bindesbøll, C., Aas, A., Ogmundsdottir, M. H., Pankiv, S., Reine, T. M., Zoncu, R., & Simonsen, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-61352-0 · Cited by 34

Reduced rate of sickle‐related complications in Brazilian patients carrying HbF‐promoting alleles at the BCL11A and HMIP‐2 loci

Leonardo, F. C., Brugnerotto, A. F., Domingos, I. F., Fertrin, K. Y., de Albuquerque, D. M., Bezerra, M. A. C., Araujo, A. S., Saad, S. T. O., Costa, F. F., Menzel, S., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.13961 · Cited by 33

A genome editing primer for the hematologist

Hoban, M. D., & Bauer, D. E. (2016) · Blood · doi:10.1182/blood-2016-01-678151 · Cited by 32

Recent trends in treatment of thalassemia

El-Beshlawy, A. M., & El-Ghamrawy, M. (2019) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2019.01.006 · Cited by 33

Short DNA sequence patterns accurately identify broadly active human enhancers

Colbran, L. L., Chen, L., & Capra, J. A. (2017) · BMC Genomics · doi:10.1186/s12864-017-3934-9 · Cited by 32

Diverse Approaches to Gene Therapy of Sickle Cell Disease

White, S. L., Hart, K. L., & Kohn, D. B. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-042921-021707 · Cited by 33

Potential new approaches to the management of the Hb Bart’s hydrops fetalis syndrome: the most severe form of α-thalassemia

King, A. J., & Higgs, D. R. (2018) · Hematology · doi:10.1182/asheducation-2018.1.353 · Cited by 35

The Daunting Economics of Therapeutic Genome Editing

Wilson, R. C., & Carroll, D. (2019) · The CRISPR Journal · doi:10.1089/crispr.2019.0052 · Cited by 33

Multiplex generation and single-cell analysis of structural variants in mammalian genomes

Pinglay, S., Lalanne, J., Daza, R. M., Kottapalli, S., Quaisar, F., Koeppel, J., Garge, R. K., Li, X., Lee, D. S., & Shendure, J. (2025) · Science · doi:10.1126/science.ado5978 · Cited by 33

Polymorphic variations influencing fetal hemoglobin levels: Association study in beta-thalassemia carriers and in normal individuals of Portuguese origin

Pereira, C., Relvas, L., Bento, C., Abade, A., Ribeiro, L., & Manco, L. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.02.001 · Cited by 32

Molecular Medicine: Found in Translation

Orkin, S. H. (2021) · Med · doi:10.1016/j.medj.2020.12.011 · Cited by 36

A unified model of human hemoglobin switching through single-cell genome editing

Shen, Y., Verboon, J. M., Zhang, Y., Liu, N., Kim, Y. J., Marglous, S., Nandakumar, S. K., Voit, R. A., Fiorini, C., Ejaz, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25298-9 · Cited by 34

Biomarker signatures of sickle cell disease severity

Du, M., Ness, S. E. V., Gordeuk, V. R., Nouraie, M. S., Nekhai, S. A., Gladwin, M. T., Steinberg, M. H., & Sebastiani, P. (2018) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2018.05.001 · Cited by 33

Mathematical modeling of erythrocyte chimerism informs genetic intervention strategies for sickle cell disease

Altrock, P. M., Brendel, C., Renella, R., Orkin, S. H., Williams, D. A., & Franziska Michor, A. (2016) · American Journal of Hematology · doi:10.1002/ajh.24449 · Cited by 31

The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil

Friedrisch, J. R., Sheehan, V., Flanagan, J. M., Baldan, A., Summarell, C. C. G., Bittar, C. M., Friedrisch, B. K., Wilke, I. I., Ribeiro, C. B., Daudt, L. E., et al. (2016) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2016.11.002 · Cited by 31

Genome Editing for β-Hemoglobinopathies: Advances and Challenges

Frati, G., & Miccio, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030482 · Cited by 31

Breaking genetic shackles: The advance of base editing in genetic disorder treatment

Xu, F., Zheng, C., Xu, W., Zhang, S., Liu, S., Chen, X., & Yao, K. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1364135 · Cited by 32

Functional Impact and Evolution of a Novel Human Polymorphic Inversion That Disrupts a Gene and Creates a Fusion Transcript

Puig, M., Castellano, D., Pantano, L., Giner-Delgado, C., Izquierdo, D., Gayà‐Vidal, M., Lucas‐Lledó, J. I., Esko, T., Terao, C., Matsuda, F., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005495 · Cited by 31

The Hematopoietic Stem and Progenitor Cell Cistrome

Hewitt, K. J., Johnson, K. D., Gao, X., Keleş, S., & Bresnick, E. H. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.01.002 · Cited by 29

Gene editing and its application for hematological diseases

Osborn, M. J., Belanto, J. J., Tolar, J., & Voytas, D. F. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-2017-z · Cited by 32

Using CRISPR to understand and manipulate gene regulation

Akıncı, E., Hamilton, M. C., Khowpinitchai, B., & Sherwood, R. I. (2021) · Development · doi:10.1242/dev.182667 · Cited by 36

Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease

Liu, L., Pertsemlidis, A., Ding, L.-H., Story, M. D., Steinberg, M. H., Sebastiani, P., Hoppe, C. C., Ballas, S. K., & Pace, B. S. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216642047 · Cited by 29

NFAT5 and SLC4A10 Loci Associate with Plasma Osmolality

Böger, C. A., Gorski, M., McMahon, G. M., Xu, H., Chang, Y.-P. C., van der Most, P. J., Navis, G., Nolte, I. M., de Borst, M. H., Zhang, W., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016080892 · Cited by 30

Safety and efficacy studies of CRISPR-Cas9 treatment of sickle cell disease highlights disease-specific responses

Frati, G., Brusson, M., Sartre, G., Mlayah, B., Félix, T., Chalumeau, A., Antoniou, P., Hardouin, G., Concordet, J., Romano, O., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.07.015 · Cited by 32

Development of a double shmiR lentivirus effectively targeting both BCL11A and ZNF410 for enhanced induction of fetal hemoglobin to treat β-hemoglobinopathies

Liu, B., Brendel, C., Vinjamur, D. S., Zhou, Y., Harris, C. E., McGuinness, M. K., Manis, J. P., Bauer, D. E., Xu, H., & Williams, D. A. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.05.002 · Cited by 29

Genome editing strategies for fetal hemoglobin induction in beta-hemoglobinopathies

Demirci, S., Leonard, A. K., & Tisdale, J. F. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa088 · Cited by 32

Making the case for chromatin profiling: a new tool to investigate the immune-regulatory landscape

Winter, D. R., Jung, S., & Amit, I. (2015) · Nature reviews. Immunology · doi:10.1038/nri3884 · Cited by 30

New Frontiers: Precise Editing of Allergen Genes Using CRISPR

Brackett, N. F., Pomés, A., & Chapman, M. D. (2022) · Frontiers in Allergy · doi:10.3389/falgy.2021.821107 · Cited by 29

CRISPR-based therapeutic genome editing for inherited blood disorders

Levesque, S., & Bauer, D. E. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01236-y · Cited by 31

CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease

Hanna, R., Frangoul, H., Piñeiro, L., McKinney, C. M., Mapara, M. Y., Dalal, J. D., Rangarajan, H. G., Atkins, H., Sharma, A., Chang, K., et al. (2026) · New England Journal of Medicine · doi:10.1056/nejmoa2415550 · Cited by 28

The genetics of hemoglobin A2 regulation in sickle cell anemia

Griffin, P. J., Sebastiani, P., Edward, H. L., Baldwin, C. T., Gladwin, M. T., Gordeuk, V. R., Chui, D. H. K., & Steinberg, M. H. (2014) · American Journal of Hematology · doi:10.1002/ajh.23811 · Cited by 27

A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemia

Adeyemo, T. A., Ojewunmi, O. O., Oyetunji, I. A., Rooks, H., Rees, D. C., Akinsulie, A., Akanmu, S. A., Thein, S. L., & Menzel, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197927 · Cited by 30

Advances in the gene therapy of monogenic blood cell diseases

Bueren, J. A., Bustamante, O. Q., Almarza, E., Navarro, S., Rı́o, P., Segovia, J. C., & Güenechea, G. (2019) · Clinical Genetics · doi:10.1111/cge.13593 · Cited by 28

Preclinical evaluation for engraftment of CD34+ cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate models

Uchida, N., Li, L., Nassehi, T., Drysdale, C. M., Yapundich, M., Gamer, J., Haro‐Mora, J. J., Demirci, S., Leonard, A. K., Bonifacino, A. C., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100247 · Cited by 28

Editing outside the body: Ex vivo gene-modification for β-hemoglobinopathy cellular therapy

Rosanwo, T. O., & Bauer, D. E. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.10.002 · Cited by 30

Do Genetic Polymorphisms Affect Fetal Hemoglobin (HbF) Levels in Patients With Sickle Cell Anemia Treated With Hydroxyurea? A Systematic Review and Pathway Analysis

Sales, R. R., Nogueira, B. L., Tosatti, J. A. G., Gomes, K. B., & Luizon, M. R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.779497 · Cited by 27

Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies

Paschoudi, K., Yannaki, E., & Psatha, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119527 · Cited by 30

Engineering guide RNA to reduce the off-target effects of CRISPR

Wu, J., & Yin, H. (2019) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2019.11.003 · Cited by 28

Transcription factor networks disproportionately enrich for heritability of blood cell phenotypes

Martin-Rufino, J. D., Caulier, A., Lee, S., Castano, N., King, E., Joubran, S. R., Jones, M. K., Goldman, S. R., Arora, U. P., Wahlster, L., et al. (2025) · Science · doi:10.1126/science.ads7951 · Cited by 30

Promise of gene therapy to treat sickle cell disease

Romero, Z. G., DeWitt, M. A., & Walters, M. C. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1536119 · Cited by 27

Genomic approaches to identifying targets for treating β hemoglobinopathies

Ngo, D., & Steinberg, M. H. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0120-2 · Cited by 27

Research in Sickle Cell Disease: From Bedside to Bench to Bedside

Cisneros, G. S., & Thein, S. L. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000584 · Cited by 25

Role of Enhancers in Development and Diseases

Maurya, S. S. (2021) · Epigenomes · doi:10.3390/epigenomes5040021 · Cited by 26

Advances in therapeutic application of CRISPR-Cas9

Sun, J., Wang, J., Zheng, D., & Hu, X. (2019) · Briefings in Functional Genomics · doi:10.1093/bfgp/elz031 · Cited by 25

Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease

Pace, B. S., Liu, L., Li, Y., & Makala, L. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215596859 · Cited by 25

BCL11A-deficient human erythropoiesis is impaired in vitro and after xenotransplantation into mice

Jang, Y., Feng, R., Palmer, L. E., Mayuranathan, T., Yao, Y., Mayberry, K. D., Zhou, S., Xu, J., Gossett, J. M., Kang, G., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024015574 · Cited by 24

High-level embryonic globin production with efficient erythroid differentiation from a K562 erythroleukemia cell line

Uchida, N., Haro‐Mora, J. J., Demirci, S., Fujita, A., Raines, L. N., Hsieh, M. M., & Tisdale, J. F. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.02.007 · Cited by 25

Genetic Modifiers of Sickle Cell Disease

Pincez, T., Ashley‐Koch, A. E., Lettre, G., & Telen, M. J. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.06.006 · Cited by 28

Association Between PIP4K2A Polymorphisms and Acute Lymphoblastic Leukemia Susceptibility

Liao, F., Yin, D., Zhang, Y., Hou, Q., Zheng, Z., Yang, L., Shu, Y., Xu, H. Y., & Li, Y. (2016) · Medicine · doi:10.1097/md.0000000000003542 · Cited by 24

Gene Editing: Powerful New Tools for Nephrology Research and Therapy

Miyagi, A., Lu, A., & Humphreys, B. D. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016020146 · Cited by 25

CURING HEMOGLOBINOPATHIES: CHALLENGES AND ADVANCES OF CONVENTIONAL AND NEW GENE THERAPY APPROACHES.

Motta, I., Ghiaccio, V., Cosentino, A., & Breda, L. (2019) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2019.067 · Cited by 25

Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia

Sales, R. R., Belisário, A. R., Faria, G., Mendes, F. G., Luizon, M. R., & Viana, M. B. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04079-2 · Cited by 26

Current and future treatments for sickle cell disease: From hematopoietic stem cell transplantation to in vivo gene therapy

Ball, J., Bradley, A., Le, A., Tisdale, J. F., & Uchida, N. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.016 · Cited by 26

Genome and Epigenome Editing to Treat Disorders of the Hematopoietic System

Mussolino, C., Alzubi, J., Pennucci, V., Turchiano, G., & Cathomen, T. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.149 · Cited by 23

CRISPR/Cas: from adaptive immune system in prokaryotes to therapeutic weapon against immune-related diseases

García-Robledo, J. E., Barrera, M. C., & Tobón, G. J. (2019) · International Reviews of Immunology · doi:10.1080/08830185.2019.1677645 · Cited by 24

Recent innovations and in-depth aspects of post-genome wide association study (Post-GWAS) to understand the genetic basis of complex phenotypes

Mortezaei, Z., & Tavallaei, M. (2021) · Heredity · doi:10.1038/s41437-021-00479-w · Cited by 28

Fetal Hemoglobin Regulation in Beta-Thalassemia

Lu, H. Y., Orkin, S. H., & Sankaran, V. G. (2023) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.12.002 · Cited by 28

Association between Variants at BCL11A Erythroid-Specific Enhancer and Fetal Hemoglobin Levels among Sickle Cell Disease Patients in Cameroon: Implications for Future Therapeutic Interventions

Pule, G. D., Bitoungui, V. J. N., Chemegni, B. C., Kengne, A. P., Antonarakis, S. E., & Wonkam, A. (2015) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2015.0124 · Cited by 24

Reactivation of Fetal Hemoglobin for Treating β-Thalassemia and Sickle Cell Disease

Cui, S., & Engel, J. D. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-7299-9_7 · Cited by 25

Clinically relevant gene editing in hematopoietic stem cells for the treatment of pyruvate kinase deficiency

Fañanas-Baquero, S., Bustamante, O. Q., Dever, D. P., Alberquilla, O., Sánchez‐Domínguez, R., Camarena, J., Ojeda-Pérez, I., Dessy-Rodríguez, M., Turk, R., Schubert, M. S., et al. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.05.001 · Cited by 22

Epigenetic Regulation of β-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing

Fontana, L., Alahouzou, Z., Miccio, A., & Antoniou, P. (2023) · Genes · doi:10.3390/genes14030577 · Cited by 27

Variation in Gamma-Globin Expression before and after Induction with Hydroxyurea Associated with BCL11A, KLF1 and TAL1

Grieco, A. J., Billett, H. H., Green, N., Driscoll, M. C., & Bouhassira, E. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129431 · Cited by 24

Manipulation of Developmental Gamma-Globin Gene Expression: an Approach for Healing Hemoglobinopathies

Venkatesan, V., Srinivasan, S., Babu, P., & Thangavel, S. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00253-20 · Cited by 22

Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment

Romano, O., Peano, C., Tagliazucchi, G. M., Petiti, L., Poletti, V., Cocchiarella, F., Rizzi, E., Severgnini, M., Cavazza, A., Rossi, C., et al. (2016) · Scientific Reports · doi:10.1038/srep24724 · Cited by 22

Zinc finger nuclease-mediated gene editing in hematopoietic stem cells results in reactivation of fetal hemoglobin in sickle cell disease

Lessard, S., Rimmelé, P., Ling, H., Moran, K., Vieira, B. F., Lin, Y.-D., Rajani, G. M., Hong, V., Reik, A., Boismenu, R., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-74716-7 · Cited by 23

Gene therapy for sickle cell disease: recent advances, clinical trials and future directions

Ballantine, J., & Tisdale, J. F. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.11.006 · Cited by 38

BCL11A +58/+55 enhancer-editing facilitates HSPC engraftment and HbF induction in rhesus macaques conditioned with a CD45 antibody-drug conjugate

Demirci, S., Zeng, J., Palchaudhuri, R., Wu, C., Abraham, D. M., Hayal, T. B., Essawi, K., Nguyen, M. A., Stasula, U., Chu, R., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.10.014 · Cited by 24

Fine-Mapping and Genome Editing Reveal An Essential Erythroid Enhancer At The HbF-Associated BCL11A Locus

Bauer, D. E., Kamran, S. C., Lessard, S., Xu, J., Fujiwara, Y., Lin, C., Shao, Z., Canver, M. C., Smith, E. C., Pinello, L., et al. (2013) · Blood · doi:10.1182/blood.v122.21.437.437 · Cited by 1

HbF-Associated Genetic Variation Marks an Erythroid Regulatory Element Essential for BCL11A Transcription and Subsequent Stage-Specific Globin Expression

Bauer, D. E., Kamran, S. C., Xu, J., Lin, C., Shao, Z., Fujiwara, Y., Voit, R. A., Porteus, M. H., Stamatoyannopoulos, J. A., & Orkin, S. H. (2012) · Blood · doi:10.1182/blood.v120.21.828.828

53. From GWAS To the Clinic: Genome-Editing the Human BCL11A Erythroid Enhancer for Fetal Globin Elevation in the Hemoglobinopathies

Reik, A., Chang, K.-H., Vierstra, J. D., Psatha, N., Stehling-Sun, S., Zhou, Y., O’Neil, C. M., Mich, A., Miller, J. C., Lee, G., et al. (2015) · Molecular Therapy · doi:10.1016/s1525-0016(16)33658-9 · Cited by 2

Recent advances in globin research using genome‐wide association studies and gene editing

Orkin, S. H. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13001 · Cited by 17

Post GWAS functional characterization of BCL11A locus toward the development of a treatment for B-thalassemia

(2013) · P-arch (Science and Technology Park of Sardinia)